Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14.

Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14.

DLBCL is an aggressive lymphoma treated with R-CHOP. Recently, attempts have been made to improve the outcome by increasing both dose-density and intensity but there have been no benefits in terms of survival. When treating malignancies RDI is important to consider but there is little published info...

Full description

Bibliographic Details
Main Authors: Antonio Gutiérrez, Leyre Bento, Antonia Maria Bautista-Gili, Francesc Garcia, Jordi Martinez-Serra, Blanca Sanchez, Clara Martorell, Jordi Gines, Lucia Garcia, Eva Gimeno, Mariana Ferraro, Raquel Del Campo, Joan Bargay, Albert Perez, Javier Vercher, Miguel Scaff, Ana Pacheco, Carmen Ballester, Florencia Garcia, Rafael Ramos, Antonio Salar, Joan Besalduch
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4409365?pdf=render

Internet

http://europepmc.org/articles/PMC4409365?pdf=render

Similar Items